nodes	percent_of_prediction	percent_of_DWPC	metapath
Levofloxacin—TOP2A—G0 and Early G1—E2F5—ocular cancer	0.0445	0.0445	CbGpPWpGaD
Levofloxacin—TOP2A—G0 and Early G1—E2F4—ocular cancer	0.0436	0.0436	CbGpPWpGaD
Levofloxacin—TOP2A—G0 and Early G1—MYBL2—ocular cancer	0.0436	0.0436	CbGpPWpGaD
Levofloxacin—TOP2A—G0 and Early G1—RBL1—ocular cancer	0.0428	0.0428	CbGpPWpGaD
Levofloxacin—TOP2A—G0 and Early G1—RBL2—ocular cancer	0.0393	0.0393	CbGpPWpGaD
Levofloxacin—TOP2A—Gastric Cancer Network 1—MYBL2—ocular cancer	0.0388	0.0388	CbGpPWpGaD
Levofloxacin—TOP2A—G0 and Early G1—RBBP4—ocular cancer	0.0371	0.0371	CbGpPWpGaD
Levofloxacin—TOP2A—G0 and Early G1—CDC25A—ocular cancer	0.0353	0.0353	CbGpPWpGaD
Levofloxacin—TOP2A—G0 and Early G1—TFDP1—ocular cancer	0.0345	0.0345	CbGpPWpGaD
Levofloxacin—TOP2A—G0 and Early G1—HDAC1—ocular cancer	0.02	0.02	CbGpPWpGaD
Levofloxacin—TOP2A—G0 and Early G1—E2F1—ocular cancer	0.0165	0.0165	CbGpPWpGaD
Levofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—E2F2—ocular cancer	0.0158	0.0158	CbGpPWpGaD
Levofloxacin—TOP2A—G0 and Early G1—CDK2—ocular cancer	0.0142	0.0142	CbGpPWpGaD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2C—ocular cancer	0.0139	0.0139	CbGpPWpGaD
Levofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—E2F3—ocular cancer	0.0137	0.0137	CbGpPWpGaD
Levofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RBBP4—ocular cancer	0.0137	0.0137	CbGpPWpGaD
Levofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDC25A—ocular cancer	0.013	0.013	CbGpPWpGaD
Levofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TFDP1—ocular cancer	0.0127	0.0127	CbGpPWpGaD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—E2F5—ocular cancer	0.0116	0.0116	CbGpPWpGaD
Levofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND3—ocular cancer	0.0115	0.0115	CbGpPWpGaD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—E2F4—ocular cancer	0.0113	0.0113	CbGpPWpGaD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—MYBL2—ocular cancer	0.0113	0.0113	CbGpPWpGaD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—E2F2—ocular cancer	0.0111	0.0111	CbGpPWpGaD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—RBL1—ocular cancer	0.0111	0.0111	CbGpPWpGaD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—RBL2—ocular cancer	0.0102	0.0102	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—CRTC1—ocular cancer	0.0101	0.0101	CbGpPWpGaD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—E2F3—ocular cancer	0.00963	0.00963	CbGpPWpGaD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—RBBP4—ocular cancer	0.00963	0.00963	CbGpPWpGaD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—CDC25A—ocular cancer	0.00916	0.00916	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—ID2—ocular cancer	0.009	0.009	CbGpPWpGaD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—TFDP1—ocular cancer	0.00895	0.00895	CbGpPWpGaD
Levofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK6—ocular cancer	0.00859	0.00859	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.00858	0.00858	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.00841	0.00841	CbGpPWpGaD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—CCND3—ocular cancer	0.00811	0.00811	CbGpPWpGaD
Levofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—HDAC1—ocular cancer	0.00739	0.00739	CbGpPWpGaD
Levofloxacin—ABCB1—HIF-1-alpha transcription factor network—ID2—ocular cancer	0.00723	0.00723	CbGpPWpGaD
Levofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—E2F1—ocular cancer	0.00608	0.00608	CbGpPWpGaD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—CDK6—ocular cancer	0.00605	0.00605	CbGpPWpGaD
Levofloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—ocular cancer	0.00601	0.00601	CbGpPWpGaD
Levofloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CCND3—ocular cancer	0.00601	0.00601	CbGpPWpGaD
Levofloxacin—TOP2A—Gastric Cancer Network 2—MYC—ocular cancer	0.00586	0.00586	CbGpPWpGaD
Levofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK2—ocular cancer	0.00524	0.00524	CbGpPWpGaD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—CCND2—ocular cancer	0.0052	0.0052	CbGpPWpGaD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—HDAC1—ocular cancer	0.0052	0.0052	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2C—ocular cancer	0.00509	0.00509	CbGpPWpGaD
Levofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—ocular cancer	0.00496	0.00496	CbGpPWpGaD
Levofloxacin—TOP2A—Gastric Cancer Network 2—TP53—ocular cancer	0.00481	0.00481	CbGpPWpGaD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2B—ocular cancer	0.00466	0.00466	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—CDKN2C—ocular cancer	0.00455	0.00455	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—GNA11—ocular cancer	0.00451	0.00451	CbGpPWpGaD
Levofloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—ocular cancer	0.00448	0.00448	CbGpPWpGaD
Levofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RB1—ocular cancer	0.00431	0.00431	CbGpPWpGaD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—E2F1—ocular cancer	0.00428	0.00428	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—E2F5—ocular cancer	0.00424	0.00424	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—GNAQ—ocular cancer	0.00419	0.00419	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—E2F4—ocular cancer	0.00415	0.00415	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—MYBL2—ocular cancer	0.00415	0.00415	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—RBL1—ocular cancer	0.00407	0.00407	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—E2F2—ocular cancer	0.00407	0.00407	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—E2F5—ocular cancer	0.00379	0.00379	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—HDAC1—ocular cancer	0.00378	0.00378	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—RBL2—ocular cancer	0.00374	0.00374	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—MYBL2—ocular cancer	0.00371	0.00371	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—E2F4—ocular cancer	0.00371	0.00371	CbGpPWpGaD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—CDK2—ocular cancer	0.00369	0.00369	CbGpPWpGaD
Levofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—ocular cancer	0.00367	0.00367	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—RBL1—ocular cancer	0.00364	0.00364	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—E2F2—ocular cancer	0.00364	0.00364	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—RBBP4—ocular cancer	0.00353	0.00353	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—E2F3—ocular cancer	0.00353	0.00353	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.00353	0.00353	CbGpPWpGaD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—CDK4—ocular cancer	0.00349	0.00349	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—CDC25A—ocular cancer	0.00336	0.00336	CbGpPWpGaD
Levofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—ocular cancer	0.00335	0.00335	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—RBL2—ocular cancer	0.00334	0.00334	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—TFDP1—ocular cancer	0.00328	0.00328	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.00324	0.00324	CbGpPWpGaD
Levofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—ocular cancer	0.0032	0.0032	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—E2F3—ocular cancer	0.00316	0.00316	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—RBBP4—ocular cancer	0.00316	0.00316	CbGpPWpGaD
Levofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—ocular cancer	0.0031	0.0031	CbGpPWpGaD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—RB1—ocular cancer	0.00303	0.00303	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—CDC25A—ocular cancer	0.003	0.003	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—CCND3—ocular cancer	0.00298	0.00298	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—TFDP1—ocular cancer	0.00293	0.00293	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.00282	0.00282	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.00279	0.00279	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.00277	0.00277	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—CCND3—ocular cancer	0.00266	0.00266	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—E2F1—ocular cancer	0.00266	0.00266	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.00264	0.00264	CbGpPWpGaD
Levofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—ocular cancer	0.00257	0.00257	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—CDK4—ocular cancer	0.00254	0.00254	CbGpPWpGaD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—ocular cancer	0.00236	0.00236	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDK2—ocular cancer	0.00229	0.00229	CbGpPWpGaD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—ocular cancer	0.00225	0.00225	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—CDK6—ocular cancer	0.00222	0.00222	CbGpPWpGaD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1A—ocular cancer	0.00218	0.00218	CbGpPWpGaD
Levofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—ocular cancer	0.00211	0.00211	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—CDK6—ocular cancer	0.00198	0.00198	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.00196	0.00196	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—CCND2—ocular cancer	0.00191	0.00191	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—HDAC1—ocular cancer	0.00191	0.00191	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—ocular cancer	0.00189	0.00189	CbGpPWpGaD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—ocular cancer	0.00181	0.00181	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.00179	0.00179	CbGpPWpGaD
Levofloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ocular cancer	0.00175	0.00175	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2B—ocular cancer	0.00171	0.00171	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.00171	0.00171	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—CCND2—ocular cancer	0.0017	0.0017	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—HDAC1—ocular cancer	0.0017	0.0017	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PSPH—ocular cancer	0.00167	0.00167	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.00165	0.00165	CbGpPWpGaD
Levofloxacin—CYP1A2—Tryptophan metabolism—MDM2—ocular cancer	0.00161	0.00161	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.00157	0.00157	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—E2F1—ocular cancer	0.00157	0.00157	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—CDKN2B—ocular cancer	0.00153	0.00153	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—EP300—ocular cancer	0.00151	0.00151	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ocular cancer	0.00147	0.00147	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ocular cancer	0.00147	0.00147	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—E2F1—ocular cancer	0.0014	0.0014	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.00137	0.00137	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.00136	0.00136	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—ocular cancer	0.00135	0.00135	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—CDK2—ocular cancer	0.00135	0.00135	CbGpPWpGaD
Levofloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	0.00134	0.00134	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—ocular cancer	0.00129	0.00129	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—ocular cancer	0.00129	0.00129	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—CDK4—ocular cancer	0.00128	0.00128	CbGpPWpGaD
Levofloxacin—CYP3A4—Tryptophan metabolism—MDM2—ocular cancer	0.00124	0.00124	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—CDK2—ocular cancer	0.00121	0.00121	CbGpPWpGaD
Levofloxacin—ABCB1—HIF-1-alpha transcription factor network—EP300—ocular cancer	0.00121	0.00121	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.00116	0.00116	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—CDK4—ocular cancer	0.00114	0.00114	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmission across Chemical Synapses—MDM2—ocular cancer	0.00114	0.00114	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.00112	0.00112	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ocular cancer	0.00112	0.00112	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ocular cancer	0.00112	0.00112	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—RB1—ocular cancer	0.00111	0.00111	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—TP53—ocular cancer	0.00108	0.00108	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.00107	0.00107	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—RB1—ocular cancer	0.000994	0.000994	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000949	0.000949	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.00092	0.00092	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PSPH—ocular cancer	0.000915	0.000915	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—TGFB1—ocular cancer	0.000911	0.000911	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	0.000882	0.000882	CbGpPWpGaD
Levofloxacin—SLC22A2—Neuronal System—MDM2—ocular cancer	0.000872	0.000872	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.00087	0.00087	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—ocular cancer	0.000866	0.000866	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—MDM2—ocular cancer	0.000848	0.000848	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—ocular cancer	0.000826	0.000826	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1A—ocular cancer	0.000799	0.000799	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—CDKN1B—ocular cancer	0.000774	0.000774	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—EP300—ocular cancer	0.00076	0.00076	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—CCND1—ocular cancer	0.000738	0.000738	CbGpPWpGaD
Levofloxacin—ABCB1—HIF-1-alpha transcription factor network—AKT1—ocular cancer	0.000731	0.000731	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PSPH—ocular cancer	0.00073	0.00073	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—CDKN1A—ocular cancer	0.000714	0.000714	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—EP300—ocular cancer	0.00068	0.00068	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—MYC—ocular cancer	0.000662	0.000662	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000645	0.000645	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmission across Chemical Synapses—HRAS—ocular cancer	0.000624	0.000624	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—MYC—ocular cancer	0.000592	0.000592	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000589	0.000589	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PSPH—ocular cancer	0.000563	0.000563	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000562	0.000562	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000543	0.000543	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—GNA11—ocular cancer	0.000527	0.000527	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000517	0.000517	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—GNAQ—ocular cancer	0.00049	0.00049	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—TP53—ocular cancer	0.000486	0.000486	CbGpPWpGaD
Levofloxacin—SLC22A2—Neuronal System—HRAS—ocular cancer	0.000478	0.000478	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000451	0.000451	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000449	0.000449	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.00037	0.00037	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000312	0.000312	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GNA11—ocular cancer	0.000288	0.000288	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GNAQ—ocular cancer	0.000268	0.000268	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GNA11—ocular cancer	0.00023	0.00023	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GNAQ—ocular cancer	0.000214	0.000214	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GNA11—ocular cancer	0.000177	0.000177	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—EP300—ocular cancer	0.000176	0.000176	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000172	0.000172	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GNAQ—ocular cancer	0.000165	0.000165	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—AKT1—ocular cancer	0.000106	0.000106	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—EP300—ocular cancer	9.62e-05	9.62e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—EP300—ocular cancer	7.68e-05	7.68e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—EP300—ocular cancer	5.92e-05	5.92e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—AKT1—ocular cancer	5.81e-05	5.81e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—AKT1—ocular cancer	4.64e-05	4.64e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—AKT1—ocular cancer	3.58e-05	3.58e-05	CbGpPWpGaD
